Evaluation of Colorectal Cancer Incidence in the United States From 2021 to 2024 Using a National Multi-Payer Claims Database
Overall, CRC incidence declined from 2021 to 2024, though rising rates among adults aged 45 to 49 highlight a growing early-onset burden. Associations between CRC incidence status and age, sex, race/ethnicity, insurance type, and region were observed, suggesting disparities that may reflect underlying equity gaps in prevention.
Authors
- Jorge Zapatier
- Jordan J. Karlitz (ORCID: https://orcid.org/0000-0001-5686-7365)
- Bettina Stieber
- Joseph W. LeMaster (ORCID: https://orcid.org/0000-0003-3026-830X)
- Igor Stukalin (ORCID: https://orcid.org/0000-0002-0943-8637)
- Shrey Gohil (ORCID: https://orcid.org/0000-0002-0169-4695)
- Ahmet Burak Ozbay (ORCID: https://orcid.org/0000-0002-8624-6313)
- Mallik Greene (ORCID: https://orcid.org/0000-0001-9363-5483)
- Joseph Anderson (ORCID: https://orcid.org/0000-0001-8266-7543)
- Jemel Bingham
Institutions
- Dartmouth College (US)
- Hartford Hospital (US)
- University of Calgary (CA)
- Exact Sciences (United States) (US)
- University of Kansas Medical Center (US)
- Texas Digestive Disease Consultants (US)
- Hartford Financial Services (United States)
Publication Details
- Journal
- Clinical Therapeutics
- Published
- 2025-11-23
- DOI
- https://doi.org/10.1016/j.clinthera.2025.10.006
- Primary Topic
- Colorectal Cancer Screening and Detection
- Type
- article
- Field-Weighted Citation Impact
- 0.00